企業プロフィール
AEON Biopharma 株価・ニュース・カタリスト
- ティッカー:
- AEON
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
0.26 USD (-7.12%)
終値
最終更新: 2026年8月17日
19.7M USD
時価総額
株価変動の要因
As of Aug 17, 2026, AEON closed down 7.12% at $0.2555. No new same-company headline was identified in the current news window.
企業概要
事業概要
AEON Biopharma is a clinical-stage neurotoxin company focused on botulinum toxin-based therapies and the potential to build a differentiated commercial asset in aesthetics and neurology. The investment case centers on whether the company can turn a highly specialized product profile into a durable franchise.
所在地とセクター分類
Headquartered in the United States and listed on NASDAQ, AEON sits in the specialty therapeutics segment. Its profile is shaped more by product execution and regulatory positioning than by broad pipeline breadth.
ビジネスモデルの特徴
AEON depends on clinical progress, commercialization strategy, and the ability to convert a focused asset base into repeatable revenue. Investors typically watch launch timing, commercial access, and strategic financing decisions.
バイオ業界での位置付け
AEON sits in a narrow but catalyst-sensitive corner of biotech where a single program can drive most of the valuation. Compared with larger peers, the stock is more exposed to execution risk and inflection-point revaluation.
今後のカタリスト
- The next three months should center on ABP-450 biosimilar development, especially follow-up with the FDA on the analytical package and the next BPD meeting steps that determine whether the program can stay on a clean regulatory path. The next checkpoint matters because it tells investors whether the program is still moving on schedule or whether the timeline needs to be reset. A clean outcome also makes it easier to think about the next regulatory or label step instead of just the current filing.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。